PTEN protein expression gradually diminishes throughout gastric carcinoma progression, correlating strongly with adverse outcomes, including gastric tumor lymph node metastasis, advanced stages, and poor prognoses [70]. The gene discussed is PTEN; the disease is gastric neoplasm.